Skip to main content
Premium Trial:

Request an Annual Quote

If You Can't Beat 'Em...

The Wall Street Journal reports that Merck is creating a unit to make generic versions of biotech drugs. The story quotes CEO Richard Clark as saying, "We believe we can become the leading provider of high-quality, competitively priced follow-on biologics." One hurdle will be the lack of an FDA approval path for these biosimilars, but the article says that the incoming Obama administration has "raised expectations that Congress will clear the regulatory path as soon as next year."

 

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.